Revitope Oncology Competitors and Similar CompaniesClear all

Exelixis's competitors and similar companies include Heidelberg Pharma.
Exelixis
Exelixis
Exelixis is an oncology company that develops cancer treatments.
Heidelberg Pharma
Heidelberg Pharma
Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries.
Founding Date
Founding Date
1994
Founding Date
1997
Type
Type
Public
Type
Public
Tags
Locations
Locations
Alameda, US HQ
Locations
Ladenburg, DE HQ
Ladenburg, DE
Employees
Employees
1,14712% decrease
Employees
60
Valuation ($)
Valuation ($)
8.2 b
Valuation ($)
158.3 m

Financial

Revenue (est.)
Revenue (est.)
$2.3b (FY, 2025)
Revenue (est.)
€1.5m (FY, 2025)
Cost of goods
Cost of goods
$83.7m (FY, 2025)
Cost of goods
(€2.5m) (FY, 2025)
Gross profit
Gross profit
$2.2b (FY, 2025)
Gross profit
€6.3m (FY, 2025)
Net income
Net income
$782.6m (FY, 2025)
Net income
(€42.3m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Heidelberg Pharma
HQ
Ladenburg, DE
Employees
60

Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries.

View company